PROVIDENCE – A research paper on the emerging threat from the H7N9 flu, written by Dr. Annie De Groot and her team at EpiVax, has been published by the journal Human Vaccines & Immunotherapeutics.
The article, “Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design,” detailed how De Groot and her team used well-established immunoinformatics tools to analyze the H7N9 protein sequences.
The research found that protein derived from closely related human-derived H7N9 strains contain fewer T cell epitopes than other recently circulating strains of influenza.
Based on that research, De Groot and her team have developed four separate vaccine recipes that are now in production.
EpiVax, a Providence-based bioscience firm, celebrated its 15th birthday on May 17 at its headquarters in the city’s Knowledge District. •